Robert B. Gerber, MD

NPI 1023059110ActiveIndividual· Internal Medicine, Pulmonary Disease· Cleveland, OH

Internal Medicine, Pulmonary Disease (MD) in Cleveland, Ohio, trained at University of Missouri, Kansas City, School of Medicine (class of 1995). Their prescriptions cost Medicare Part D more than their services did: $1,117,579 for 2,723 claims, against $41,437 paid for services in 2024. Actelion Pharmaceuticals US, Inc. was the largest of 2 companies reporting payments in 2025, $39.80 in all, mostly food and beverage.

Overview

NPI	1023059110
Status	Active
Entity type	Individual
Credential	MD
Sole proprietor	No
NPI issued	Jun 9, 2006
Last updated in NPPES	Aug 14, 2015

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Pulmonary Disease Primary	207RP1001X	35-077844	OH

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Oct 9, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 4, 2026	No match	—
New York OMIG · Nov 4, 2026	No match	—
Ohio Medicaid · Nov 4, 2026	No match	—
Pennsylvania Medicheck · Nov 4, 2026	No match	—
Washington HCA · Nov 4, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Pulmonary Disease (OH)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	299
Services billed	680 across 23 procedure codes
Paid by Medicare	$41,437

Part D prescriptions in 2024

Prescriptions (claims)	2,723 · 3,541 30-day fills
Patients	427
Total drug cost	$1,117,579
Generic share	40% of claims

Medicare sources and data years

Education and affiliations

Medical school	University of Missouri, Kansas City, School of Medicine
Graduation year	1995
Medicare specialty	Pulmonary Disease
Telehealth	Offers telehealth